Clinical Trial Update: Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating decidua stromal cells for steroid-resistant acute graft-versus-host disease after allogeneic HSCT is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Decidua stromal cells (decidua stromal cells)

Snippet

Sponsor: Mats Remberger | Conditions: GVHD, Acute | Phase 2 | Status: RECRUITING